Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liberty All-Star Equity

6.44
-0.0200-0.31%
Post-market: 6.42-0.0200-0.31%19:59 EDT
Volume:544.06K
Turnover:3.51M
Market Cap:1.86B
PE:5.19
High:6.51
Open:6.49
Low:6.42
Close:6.46
Loading ...

McEwen Mining Q4 And Year-End 2024 Results Conference Call

GlobeNewswire
·
18 Mar

Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States

Business Wire
·
17 Mar

Worldline North America Named 'Great Place to Work' for the Fourth Consecutive Year

CNW Group
·
14 Mar

O-I GLASS TO DETAIL STRATEGIC INITIATIVES TO DRIVE LONG-TERM VALUE

GlobeNewswire
·
14 Mar

Press Release: ARIANNE PHOSPHATE NAMES PIERRE FITZGIBBON AS A STRATEGIC ADVISOR TO THE COMPANY

Dow Jones
·
13 Mar

Rio Tinto Secures $9 Billion in Bond Issuance to Bolster Growth

TIPRANKS
·
12 Mar

The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets - regulated information

GlobeNewswire
·
12 Mar

Nutrien Prices Offering of an Aggregate of US$1.0 Billion of 2-Year and 7-Year Senior Notes

Business Wire
·
12 Mar

Forestar Group Inc. Announces Pricing Terms of Tender Offer for Any and All of its 3.850% Senior Notes due 2026

Business Wire
·
12 Mar

Press Release: Dow Announces the Early Results of its Cash Tender Offer

Dow Jones
·
11 Mar

Extra Space Announces Pricing of $500 Million of 5.400% Senior Notes due 2035

PR Newswire
·
11 Mar

Press Release: Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs

Dow Jones
·
11 Mar

EQT Announces Pricing of Tender Offer for 3.900% Senior Notes due 2027

PR Newswire
·
11 Mar

Enstar Group Limited Announces Any And All Cash Tender Offer For Junior Subordinated Notes Due 2040

GlobeNewswire
·
10 Mar

Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results

ACCESS Newswire
·
07 Mar

InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

GlobeNewswire
·
07 Mar

Amcor Enters Five-Year $3.75 Billion Revolving Credit Facility Agreement

MT Newswires Live
·
07 Mar

Diamondback Energy Prices Offering of Senior Notes

GlobeNewswire
·
07 Mar

Cosmo Pharmaceuticals Delivers Record 2024 Results - Completes Phase III Enrollment for Androgenetic Alopecia in Males - Proposes Increased Dividend of 2.05 per share - Reinforcing Shareholder Value and Growth Momentum into 2025

Newsfile
·
06 Mar

Logitech Shares Plans to Accelerate Profitable Growth at Analyst & Investor Day

Business Wire
·
06 Mar